Toxic Epidermal Necrolysis : A Case Report.
作者信息
Kumar N, Walia N S, Sandhu M S, Grover N
机构信息
Comdt, Armed Forces Clinic, DHQ, Dalhousie Road, New Delhi-11.
Classified Specialist (Dermatology & STD), 153 GH C/o 56 APO, Delhi Cantt.
出版信息
Med J Armed Forces India. 2006 Jul;62(3):271-2. doi: 10.1016/S0377-1237(06)80018-3. Epub 2011 Jul 21.
Abstract
摘要
相似文献
1
Toxic Epidermal Necrolysis : A Case Report.中毒性表皮坏死松解症：一例报告
Med J Armed Forces India. 2006 Jul;62(3):271-2. doi: 10.1016/S0377-1237(06)80018-3. Epub 2011 Jul 21.
2
Usefulness of case report literature in determining drugs responsible for toxic epidermal necrolysis.病例报告文献在确定导致中毒性表皮坏死松解症的药物方面的作用。
J Am Acad Dermatol. 1989 Aug;21(2 Pt 1):317-22. doi: 10.1016/s0190-9622(89)70176-6.
3
Ofloxacin: a probable cause of toxic epidermal necrolysis.氧氟沙星：中毒性表皮坏死松解症的一个可能病因。
Ann Pharmacother. 2001 Nov;35(11):1388-90. doi: 10.1345/aph.1Z433.
4
Toxic epidermal necrolysis.中毒性表皮坏死松解症
Nutr Clin Pract. 1991 Feb;6(1):18-20. doi: 10.1177/011542659100600118.
5
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case-Control Study.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症与门诊护理中除抗癫痫药和抗生素以外的常用药物有关：一项基于人群的病例对照研究。
Drug Saf. 2019 Jan;42(1):55-66. doi: 10.1007/s40264-018-0711-x.
6
Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.药物作为儿童史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的危险因素：一项汇总分析。
Pediatrics. 2009 Feb;123(2):e297-304. doi: 10.1542/peds.2008-1923. Epub 2009 Jan 19.
7
Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.重症多形红斑、史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的临床模式与病因之间的相关性：一项国际前瞻性研究的结果
Arch Dermatol. 2002 Aug;138(8):1019-24. doi: 10.1001/archderm.138.8.1019.
8
Successful dabrafenib transition after vemurafenib-induced toxic epidermal necrolysis in a patient with metastatic melanoma.一名转移性黑色素瘤患者在维莫非尼诱导的中毒性表皮坏死松解症后成功转换为达拉非尼治疗。
JAAD Case Rep. 2018 Oct 10;4(9):930-933. doi: 10.1016/j.jdcr.2018.08.003. eCollection 2018 Oct.
9
Comparing mortality outcomes of major burns and toxic epidermal necrolysis in a tertiary burns centre.比较三级烧伤中心严重烧伤和中毒性表皮坏死松解症的死亡率结果。
Burns. 2014 Dec;40(8):1743-7. doi: 10.1016/j.burns.2014.03.012. Epub 2014 May 9.
10
Toxic epidermal necrolysis after acute burn injury.急性烧伤后中毒性表皮坏死松解症
Ann Burns Fire Disasters. 2018 Dec 31;31(4):266-270.
引用本文的文献
1
Severe cutaneous adverse drug reactions manifesting as Stevens-Johnson syndrome and toxic epidermal necrolysis reported to the national pharmacovigilance center in Nigeria: a database review from 2004 to 2017.向尼日利亚国家药物警戒中心报告的表现为史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的严重皮肤药物不良反应：2004年至2017年的数据库回顾
Ther Adv Drug Saf. 2020 Feb 12;11:2042098620905998. doi: 10.1177/2042098620905998. eCollection 2020.
本文引用的文献
1
Treatment of drug-induced toxic epidermal necrolysis (Lyell's syndrome) with intravenous human immunoglobulins.静脉注射人免疫球蛋白治疗药物性中毒性表皮坏死松解症（莱尔综合征）
Burns. 2001 Sep;27(6):652-5. doi: 10.1016/s0305-4179(01)00005-5.
2
Toxic epidermal necrolysis.中毒性表皮坏死松解症
Dermatol Clin. 2000 Jul;18(3):485-95, ix. doi: 10.1016/s0733-8635(05)70196-0.
3
Epidermal apoptotic cell death in erythema multiforme and Stevens-Johnson syndrome. Contribution of perforin-positive cell infiltration.
Arch Dermatol. 1997 Jul;133(7):845-9.
4
Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.药物使用与史蒂文斯-约翰逊综合征或中毒性表皮坏死松解症的风险。
N Engl J Med. 1995 Dec 14;333(24):1600-7. doi: 10.1056/NEJM199512143332404.
5
Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids.在不使用皮质类固醇的情况下，中毒性表皮坏死松解症患者在烧伤中心的生存率得到提高。
Ann Surg. 1986 Nov;204(5):503-12. doi: 10.1097/00000658-198611000-00001.
Zotero 插件